Company / Gross Margin
Omnicell Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
42.5%
FY2025
5-year range
42.4% / 48.7%
FY2021-FY2025
Trend
+0.3%
vs FY2024
Sector context
#72 of 96
Health Care
What the data says
Omnicell's gross margin of 42.5% is lower than 75% of companies in the Health Care sector (FY2025). Gross Margin returned to growth in FY2025 after 3 years of decline, reaching 42.5%.
Based on SEC 10-K filings.
42.5% in FY2025 with a 5-year CAGR of -4.8%.
Remained stable around 42.5% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- -3.8pp
- 5-Year Change
- -4.8pp
- 10-Year Change
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 96This company 42.5% Sector average 53.6%
▼
-20.7% below sector average
Key checks
Key Insights
- In FY2025, gross margin increased 0.3% year-over-year.
- Currently 11.1pp below the Health Care sector average.
- Peak gross margin was recorded in FY2016.
- Lowest gross margin in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 42.5% | +0.3% |
| FY2024 | 42.4% | -2.2% |
| FY2023 | 43.3% | -6.5% |
| FY2022 | 46.3% | -4.9% |
| FY2021 | 48.7% | +3.0% |
| FY2020 | 47.3% | +5.8% |
| FY2019 | 44.7% | -5.5% |
| FY2018 | 47.3% | +5.8% |
| FY2017 | 44.7% | -15.7% |
| FY2016 | 53.0% | +3.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026